HCAHCA
US • —
$389.89
P/E
13.41
PEG
0.46
FCF Yield
—
Rev Growth YoY
+6.7% YoY
Gross Margin
85.0%
Health Score
6/10
D/E Ratio
54.20
Confidence
LOW
Business Snapshot
HCA Healthcare operates as a leading provider of healthcare services in the United States, primarily generating revenue through its network of hospitals, outpatient centers, and related healthcare facilities. The company operates within the highly regulated and capital-intensive hospital and healthcare services market, holding a dominant position as one of the nation's largest for-profit hospital operators. The company's defining characteristic is its substantial scale and established market presence across multiple states, which provides negotiating leverage with payers and suppliers. While specific financial scale metrics are not fully available, its market cap and revenue figures are absent from the data, limiting a full assessment of its size relative to peers.
Financial Health
Gross margin stands at an exceptionally high 85.0%, though no prior-year comparison is available to assess the trend. The net margin is 8.9%, indicating a reasonable level of profitability after all expenses, but again without a historical comparison...
Risk Assessment
- DEBT / LIQUIDITY — Debt/equity of 54.2x indicates a highly leveraged capital structure, significantly increasing financial risk.
- LIQUIDITY — Current ratio of 0.97x is below 1.0x, suggesting the company may have difficulty covering its short-term obligations with its current assets.
- VALUATION DIVERGENCE — DCF estimates could not be calculated due to negative or unavailable free cash flow, leaving the intrinsic valuation picture entirely unclear.
- TECHNICALS — RSI, MACD, and moving average data unavailable for this period; momentum cannot be independently confirmed.
- DATA COMPLETENESS — Several core fundamental metrics are missing, including market cap, revenue, and free cash flow, limiting the depth of financial analysis....
Gross margin stands at an exceptionally high 85.0%, though no prior-year comparison is available to assess the trend. The net margin is 8.9%, indicating a reasonable level of profitability after all expenses, but again without a historical comparison. The balance sheet shows signs of significant leverage, with a debt/equity ratio of 54.2x, and a current ratio of 0.97x, indicating that current liabilities slightly exceed current assets, which can signal near-term liquidity tightness. Free cash flow and FCF yield are not provided in the data. Overall, the company demonstrates strong margins but operates with a highly leveraged balance sheet, which reduces financial flexibility and could constrain debt-funded reinvestment or dividend capacity for equity holders.
- DEBT / LIQUIDITY — Debt/equity of 54.2x indicates a highly leveraged capital structure, significantly increasing financial risk. - LIQUIDITY — Current ratio of 0.97x is below 1.0x, suggesting the company may have difficulty covering its short-term obligations with its current assets. - VALUATION DIVERGENCE — DCF estimates could not be calculated due to negative or unavailable free cash flow, leaving the intrinsic valuation picture entirely unclear. - TECHNICALS — RSI, MACD, and moving average data unavailable for this period; momentum cannot be independently confirmed. - DATA COMPLETENESS — Several core fundamental metrics are missing, including market cap, revenue, and free cash flow, limiting the depth of financial analysis.
Unlock the full AI report
Full 8-section analysis includes:
Metric deep-dives